NCT05312645

Diclofenac Gel in the Treatment of Cervicogenic Headache

Diclofenac Gel in the Treatment of Cervicogenic Headache: A Randomized, Double-Blind, Controlled Trial

• Status: Withdrawn
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Loma Linda University · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

The intervention will consist of the nursing staff applying 2 grams of diclofenac 1% gel topically to the posterior cervical region four times daily. The control group will receive petroleum jelly topically to the posterior cervical region four times daily. Patients will receive a pre-intervention and post-intervention survey incorporating the Numeric Assessment Scale and Headache Impact Test-6.

Conditions

• Cervicogenic Headache

Interventions

Type	Name	Description
DRUG	Diclofenac 1% Topical	2 grams topically four times daily for 2 weeks to posterior cervical spine
OTHER	Petroleum Jelly	2 grams topically four times daily for 2 weeks to posterior cervical spine

Timeline

• Start date: 2023-12-01
• Primary completion: 2024-08-21
• Completion: 2024-08-21
• First posted: 2022-04-05
• Last updated: 2025-01-23

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study